GlassScriptPhysician profile
Kelsey Schaeffer
NPI 1588177182
$1,649.01
in general payments reported to CMS, 2019-2025
10 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $294 · 2022: $283 · 2023: $161 · 2024: $412 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $959 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.73 |
| Education | $113.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $793.34 | 2021-2025 | Dupixent |
| Galderma Laboratories, L.P. | $199.27 | 2024 | |
| Pfizer INC. | $163.83 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $116.32 | 2023-2024 | Sotyktu |
| Abbvie INC. | $107.08 | 2021 | |
| Organon LLC | $89.46 | 2025 | Vtama |
| Genzyme Corporation | $88.49 | 2021-2025 | |
| Lilly USA, LLC | $59.84 | 2025 | Ebglyss |
| Incyte Corporation | $21.25 | 2024 | Opzelura |
| Biofrontera INC. | $10.13 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.